Chemocentryx Inc (CCXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 11,763 | 5,459 | 2,315 | 17,743 | 1,813 |
| Cost of Goods | 803 | 205 | N/A | N/A | N/A |
| Gross Profit | 10,960 | 5,254 | 2,013 | 17,743 | 1,813 |
| Operating Expenses | 43,337 | 43,692 | 42,366 | 39,546 | 40,551 |
| Operating Income | -31,574 | -38,233 | -40,051 | -21,803 | -38,738 |
| Interest Expense | 586 | 597 | 643 | 668 | 695 |
| Other Income | 509 | 222 | 166 | 164 | 224 |
| Pre-tax Income | -31,651 | -38,608 | -40,528 | -22,307 | -39,209 |
| Net Income Continuous | -31,651 | -38,608 | -40,528 | -22,307 | -39,209 |
| Net Income | $-31,651 | $-38,608 | $-40,528 | $-22,307 | $-39,209 |
| EPS Basic Total Ops | -0.44 | -0.55 | -0.58 | -0.32 | -0.56 |
| EPS Basic Continuous Ops | -0.44 | -0.55 | -0.58 | -0.32 | -0.56 |
| EPS Diluted Total Ops | -0.44 | -0.55 | -0.58 | -0.32 | -0.56 |
| EPS Diluted Continuous Ops | -0.44 | -0.55 | -0.58 | -0.32 | -0.56 |
| EPS Diluted Before Non-Recurring Items | -0.44 | -0.55 | -0.58 | -0.32 | -0.56 |
| EBITDA(a) | $-30,550 | $-37,216 | $-40,410 | $-19,425 | $-37,735 |